UMB Bank’s Veracyte VCYT Stock Holding History

UMB Bank’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$25K	Sell	425 -85	-17%	-$3.56K	﹤0.01%	1598
2026 Q1	$16.4K	Buy	510 +15	+3%	+$555	﹤0.01%	1670
2025 Q4	$20.8K	Buy	495 +134	+37%	+$5.4K	﹤0.01%	1547
2025 Q3	$12.4K	Buy	+361	New	+$10.4K	﹤0.01%	1600

Other funds holding VCYT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

UMB Bank's VCYT Position: Q2 2026 in Review

UMB Bank reduced its Veracyte (VCYT) stake by 17% in Q2 2026, selling an estimated $3.56K and leaving 425 shares worth $25K. The position accounts for ﹤0.01% of the portfolio, ranked #1598.

UMB Bank first reported a position in VCYT in Q3 2025 and has held it in 4 quarters since. 371 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.

UMB Bank held 425 shares of Veracyte worth $25K as of Q2 2026.
UMB Bank sold 85 Veracyte shares in Q2 2026, an estimated $3.56K.
Veracyte made up ﹤0.01% of UMB Bank's portfolio in Q2 2026, its #1598 holding.
UMB Bank first reported a position in Veracyte in Q3 2025 and has held it in 4 quarters since.
371 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.